Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate
Preparation (M1) of Irbesartan (I), or its salt involves: coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl) phenylboronic acid (III) in a solvent medium, in the presence of an organic or inorganic base, forming a salt with the tetrazole ring of...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
02.04.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Preparation (M1) of Irbesartan (I), or its salt involves: coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl) phenylboronic acid (III) in a solvent medium, in the presence of an organic or inorganic base, forming a salt with the tetrazole ring of (III), at 25 - 150[deg]C, with a palladium catalyst and optionally with ligand, to obtain (I) in the form of an aqueous solution of one its organic- or inorganic-base salts, followed by acidification and recrystallization. Preparation (M1) of Irbesartan (I), or its salt involves: (1) coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl) phenylboronic acid (III) in a solvent medium selected from an organic polar or aqueous solvent, or a mixture of water and water-miscible solvent or a biphasic system, in the presence of an organic or inorganic base, capable of forming a salt with the tetrazole ring of (III), at 25 - 150[deg]C, with a palladium catalyst and, optionally a ligan |
---|---|
AbstractList | Preparation (M1) of Irbesartan (I), or its salt involves: coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl) phenylboronic acid (III) in a solvent medium, in the presence of an organic or inorganic base, forming a salt with the tetrazole ring of (III), at 25 - 150[deg]C, with a palladium catalyst and optionally with ligand, to obtain (I) in the form of an aqueous solution of one its organic- or inorganic-base salts, followed by acidification and recrystallization. Preparation (M1) of Irbesartan (I), or its salt involves: (1) coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl) phenylboronic acid (III) in a solvent medium selected from an organic polar or aqueous solvent, or a mixture of water and water-miscible solvent or a biphasic system, in the presence of an organic or inorganic base, capable of forming a salt with the tetrazole ring of (III), at 25 - 150[deg]C, with a palladium catalyst and, optionally a ligan |
Author | HUGUET CLOTET JOAN DALMASES BARJOAN PERE |
Author_xml | – fullname: DALMASES BARJOAN PERE – fullname: HUGUET CLOTET JOAN |
BookMark | eNqNjbsKwkAQAK_Qwtc_rJ0WQkII2EpQbLSyD5vLxltI9o67jZC_N4UfYDUwDMzaLMQLrYx9kDrfQucj-EaRheUNCMFhHNDSqGyx7ydAq_whsH4IfpQWDhwbShgV5Qg4C9YEaRJ1lDgBi1IcqGVU2pplh32i3Y8bs79dX9X9RMHXlMK8EdK6euZZnpflOSsuxT_NFxHBQIk |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | CN101155803A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN101155803A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:48:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN101155803A3 |
Notes | Application Number: CN200680005979 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080402&DB=EPODOC&CC=CN&NR=101155803A |
ParticipantIDs | epo_espacenet_CN101155803A |
PublicationCentury | 2000 |
PublicationDate | 20080402 |
PublicationDateYYYYMMDD | 2008-04-02 |
PublicationDate_xml | – month: 04 year: 2008 text: 20080402 day: 02 |
PublicationDecade | 2000 |
PublicationYear | 2008 |
RelatedCompanies | INKE SA |
RelatedCompanies_xml | – name: INKE SA |
Score | 2.780824 |
Snippet | Preparation (M1) of Irbesartan (I), or its salt involves: coupling 2-butyl-3-(4'-iodobenzyl)-1,3-diazaspiro[4,4]non-1-en-4-one (II) with 2-(1H-tetrazol-5-yl)... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | Method for obtaining a pharmaceutically active compound (irbesartan) and its synthesis intermediate |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080402&DB=EPODOC&locale=&CC=CN&NR=101155803A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dS8MwFL3MKeqbTkXnBxGk6EOx9ou-DHHpxhDaDZmyt9GkHatIW5aIzF_vTba5vWjpQ0ggNCE39zS59xyAm8BWMNpOTcsJmJIw803EcY6Z4fPgcnTJmsQ1iv3eq_s88kY1eF_lwmie0C9NjogWxdHepd6vq_UhVqhjK8U9y7GqfOwOW6Gx-jsOcE3aRthudQb9sE8NSls0NuIXxLoIfbzAcp62YFvBaMWz33lrq6yUatOldA9gZ4C9FfIQat_TBuzRlfJaA3aj5YU3Fpe2J46AR1rsmSDKJCWTC2UHkpBqunkq_TEnid7CiAoWV5pJ5DafsUzgEkmKO5JgRS4FEfMCoZ_IBVGEETOdQCKzY7judoa0Z-LXjn-nZkzj9cCcE6gXZZGdAuG-l6IbSvmEp26Crx8odMSY5TEsT86g-Xc_zf8az2F_ETHhmpZ9AXU5-8wu0S1LdqXn8webK5Nl |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1dT8IwFL1BNOKbokbxqyZm0YfFsS_3Qox0EFQ2iEHDG1m3EWbMILTG4K_3toDwossemjZp1qa396y99xyAK8-UMNpMdMPymJQwc3XEcZae4lO1Y3TJisQ1CN3Wq_3Ud_oFeF_mwiie0C9FjogWFaO9C7VfT1aHWL6KreS3LMOq8X2zV_O15d-xh2vS1Px6rdHt-B2qUVqjoRa-INZF6ON4hvWwAZt3kp1XQqe3usxKmay7lOYubHWxt1zsQeF7VIYSXSqvlWE7WFx4Y3Fhe3wf4kCJPRNEmWTMxFzZgURkMlo_lf6YkUhtYUQGi0vNJHKdTVnKcYlE-Q2JsCITnPBZjtCPZ5xIwoipSiAR6QFcNhs92tLxawe_UzOg4Wpg1iEU83GeHgGJXSdBN5TEwzixI3xdT6IjxgyHYXl4DJW_-6n813gBpVYvaA_aj-HzCezMoyds3TBPoSimn-kZumjBztXc_gCpVZZS |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Method+for+obtaining+a+pharmaceutically+active+compound+%28irbesartan%29+and+its+synthesis+intermediate&rft.inventor=DALMASES+BARJOAN+PERE&rft.inventor=HUGUET+CLOTET+JOAN&rft.date=2008-04-02&rft.externalDBID=A&rft.externalDocID=CN101155803A |